Publications by authors named "Abulimiti Adilijiang"

Article Synopsis
  • * Researchers analyzed data from 151 AIS patients treated with MT from 2019 to 2021, finding that 31.1% achieved FPE.
  • * Key factors linked to higher FPE rates included lower body mass index (BMI), absence of intracranial atherosclerotic stenosis, not having internal carotid artery occlusion, and lower total cholesterol levels, suggesting these factors may influence patient recovery after MT.
View Article and Find Full Text PDF

Objective: We aimed to investigate the association of lipid parameters with parenchymal hemorrhage (PH) and early neurological improvement (ENI) after mechanical thrombectomy (MT) in stroke patients.

Methods: We retrospectively analyzed consecutive patients who underwent MT between January 2019 and February 2022 at a tertiary stroke center. PH was diagnosed and classified as PH-1 and PH-2 according to the European Cooperative Acute Stroke Study definition.

View Article and Find Full Text PDF

Cerebral demyelination is possibly one of the main pathological factors involved in the development of schizophrenia. Our previous studies have showed that Areca catechu nut extract could ameliorate cognitive decline by facilitating myelination processes in the frontal cortex in a cuprizone (CPZ)-induced mouse model of schizophrenia. The aim of the present study was to evaluate the effects of arecoline, one of the alkaloids in A.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate whether Areca catechu L. (Areca nut) could improve depressive symptoms and cognitive decline by promoting myelination in the prefrontal cortex using a mouse model of demyelination.
  • Mice showed hyperactivity, memory issues, and depressive behaviors due to demyelination but exhibited improvements in these areas after being fed with Areca nut extract for 8 weeks.
  • The results suggested that Areca nut extract enhanced the expression of myelin-related proteins and brain-derived neurotrophic factor (BDNF), indicating potential benefits for brain health through myelination.
View Article and Find Full Text PDF

Studies have implicated astrocytic dysfunction in Alzheimer's disease (AD). However, the role of astrocytes in the pathophysiology and treatment of the disease is poorly characterized. Here, we identified astrocytes as independent key factors involved in several Alzheimer-like phenotypes in an APP/PS1 mouse model, including amyloid pathology, altered neuronal and synaptic properties, and impaired cognition.

View Article and Find Full Text PDF

Objective: To evaluate the effects of Abnormal Savda Munziq (ASMq), a traditional herbal medicine, for the prevention and treatment of human diseases, e.g. bowel cancer.

View Article and Find Full Text PDF

Schizophrenia is a serious psychiatric illness with an unclear cause. One theory is that demyelination of white matter is one of the main pathological factors involved in the development of schizophrenia. The current study evaluated the protective effects of Areca catechu nut extract (ANE) on a cuprizone-induced demyelination mouse model.

View Article and Find Full Text PDF

Previous studies have demonstrated that quetiapine (QTP) may have neuroprotective properties; however, the underlying mechanisms have not been fully elucidated. In this study, we identified a novel mechanism by which QTP increased the synthesis of ATP in astrocytes and protected GABAergic neurons from aging-induced death. In 12-month-old mice, QTP significantly improved cell number of GABAegic neurons in the cortex and ameliorated anxiety-like behaviors compared to control group.

View Article and Find Full Text PDF

Cuprizone (CPZ) induced demyelinating mouse has been used as an animal model to examine the assumed roles of altered oligodendrocytes in the pathophysiology and treatment of schizophrenia. The objectives of this study were to examine the effect of olanzapine, an atypical antipsychotic, on cuprizone-induced neuropathological changes in the frontal cortex of C57BL/6 mice, and to explore the underlying mechanism for the possible protective effects. The effects of six-week olanzapine (10 mg/kg/day) treatments on neuropathological changes were examined by immunohistochemistry and Western-blot analyses.

View Article and Find Full Text PDF

Aims: Oligodendrocyte/myelin abnormalities may be an important component of the pathogenesis found in schizophrenia. The aim of this current study was to examine the possible effects of the antipsychotic drugs (APDs) haloperidol (HAL), olanzapine (OLA), and quetiapine (QUE) on the development of oligodendroglial lineage cells.

Main Methods: CG4 cells, an oligodendrocyte progenitor cell line, were treated with various concentrations of HAL, OLA, or QUE for specific periods.

View Article and Find Full Text PDF

Increasing evidence supports an important role of oligodendrocytes and myelination in the pathogenesis of schizophrenia. Oligodendrocytes are the myelin-producing cells in the central nervous system. To test the myelination dysfunction hypothesis of schizophrenia, possible myelination dysfunction was evaluated in a phencyclidine (PCP)-induced neurodevelopmental model of schizophrenia.

View Article and Find Full Text PDF